Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

Cataldo A, Piovan C, Plantamura I, D'Ippolito E, Camelliti S, Casalini P, Giussani M, Déas O, Cairo S, Judde JG, Tagliabue E, Iorio MV.

Oncotarget. 2018 Jun 15;9(46):27920-27928. doi: 10.18632/oncotarget.24723. eCollection 2018 Jun 15.

2.

Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes.

Piovan C, Marin V, Scavullo C, Corna S, Giuliani E, Bossi S, Galy A, Fenard D, Bordignon C, Rizzardi GP, Bovolenta C.

Mol Ther Methods Clin Dev. 2017 Mar 8;5:22-30. doi: 10.1016/j.omtm.2017.02.003. eCollection 2017 Jun 16.

3.

Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein.

Zucchelli E, Pema M, Stornaiuolo A, Piovan C, Scavullo C, Giuliani E, Bossi S, Corna S, Asperti C, Bordignon C, Rizzardi GP, Bovolenta C.

Mol Ther Methods Clin Dev. 2017 Jan 11;4:102-114. doi: 10.1016/j.omtm.2017.01.002. eCollection 2017 Mar 17.

4.

Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM.

J Exp Med. 2017 May 1;214(5):1557. doi: 10.1084/jem.2012095001172017c. Epub 2017 Jan 19. No abstract available.

5.

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

D'Ippolito E, Plantamura I, Bongiovanni L, Casalini P, Baroni S, Piovan C, Orlandi R, Gualeni AV, Gloghini A, Rossini A, Cresta S, Tessari A, De Braud F, Di Leva G, Tripodo C, Iorio MV.

Cancer Res. 2016 Sep 15;76(18):5562-72. doi: 10.1158/0008-5472.CAN-16-0140. Epub 2016 Jul 11.

6.

RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope.

Marin V, Stornaiuolo A, Piovan C, Corna S, Bossi S, Pema M, Giuliani E, Scavullo C, Zucchelli E, Bordignon C, Rizzardi GP, Bovolenta C.

Mol Ther Methods Clin Dev. 2016 May 11;3:16033. doi: 10.1038/mtm.2016.33. eCollection 2016.

7.
8.

Human anti-nucleolin recombinant immunoagent for cancer therapy.

Palmieri D, Richmond T, Piovan C, Sheetz T, Zanesi N, Troise F, James C, Wernicke D, Nyei F, Gordon TJ, Consiglio J, Salvatore F, Coppola V, Pichiorri F, De Lorenzo C, Croce CM.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9418-23. doi: 10.1073/pnas.1507087112. Epub 2015 Jul 13.

9.

A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.

Jeon YJ, Middleton J, Kim T, Laganà A, Piovan C, Secchiero P, Nuovo GJ, Cui R, Joshi P, Romano G, Di Leva G, Lee BK, Sun HL, Kim Y, Fadda P, Alder H, Garofalo M, Croce CM.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3355-64. doi: 10.1073/pnas.1504630112. Epub 2015 Jun 15. Erratum in: Proc Natl Acad Sci U S A. 2017 Mar 21;114(12 ):E2542.

10.

Generation of mouse lines conditionally over-expressing microRNA using the Rosa26-Lox-Stop-Lox system.

Piovan C, Amari F, Lovat F, Chen Q, Coppola V.

Methods Mol Biol. 2014;1194:203-24. doi: 10.1007/978-1-4939-1215-5_11.

PMID:
25064105
11.

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

Zappasodi R, Cavanè A, Iorio MV, Tortoreto M, Guarnotta C, Ruggiero G, Piovan C, Magni M, Zaffaroni N, Tagliabue E, Croce CM, Zunino F, Gianni AM, Di Nicola M.

Int J Cancer. 2014 Nov 1;135(9):2034-45. doi: 10.1002/ijc.28852. Epub 2014 Mar 26. Erratum in: Int J Cancer. 2017 Nov 1;141(9):E6.

12.

miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.

Gandellini P, Giannoni E, Casamichele A, Taddei ML, Callari M, Piovan C, Valdagni R, Pierotti MA, Zaffaroni N, Chiarugi P.

Antioxid Redox Signal. 2014 Mar 1;20(7):1045-59. doi: 10.1089/ars.2013.5292. Epub 2013 Sep 17.

13.

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM.

J Exp Med. 2013 May 6;210(5):951-68. doi: 10.1084/jem.20120950. Epub 2013 Apr 22. Erratum in: J Exp Med. 2017 May 1;214(5):1557.

14.

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.

Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM.

PLoS Genet. 2013;9(3):e1003311. doi: 10.1371/journal.pgen.1003311. Epub 2013 Mar 7. Erratum in: PLoS Genet. 2013 Apr;9(4). doi:10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46. Ramasamy, Santhanam [corrected to Santhanam, Ramasamy].

15.

[The language disorders in schizophrenia in neurolinguistic and psycholinguistic perspectives].

Piovan C.

Riv Psichiatr. 2012 Mar-Apr;47(2):96-105. doi: 10.1708/1069.11714. Review. Italian.

PMID:
22622246
16.

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.

Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM.

Mol Oncol. 2012 Aug;6(4):458-72. doi: 10.1016/j.molonc.2012.03.003. Epub 2012 Apr 19.

17.

Breast cancer and microRNAs: therapeutic impact.

Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E.

Breast. 2011 Oct;20 Suppl 3:S63-70. doi: 10.1016/S0960-9776(11)70297-1. Review.

18.

Interplay between microRNAs and the epigenetic machinery: an intricate network.

Iorio MV, Piovan C, Croce CM.

Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):694-701. doi: 10.1016/j.bbagrm.2010.05.005. Epub 2010 May 20. Review.

PMID:
20493980
19.

MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM.

J Natl Cancer Inst. 2010 May 19;102(10):706-21. doi: 10.1093/jnci/djq102. Epub 2010 Apr 13.

20.

microRNA-205 regulates HER3 in human breast cancer.

Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Ménard S, Croce CM, Tagliabue E.

Cancer Res. 2009 Mar 15;69(6):2195-200. doi: 10.1158/0008-5472.CAN-08-2920. Epub 2009 Mar 10.

21.

UCbase & miRfunc: a database of ultraconserved sequences and microRNA function.

Taccioli C, Fabbri E, Visone R, Volinia S, Calin GA, Fong LY, Gambari R, Bottoni A, Acunzo M, Hagan J, Iorio MV, Piovan C, Romano G, Croce CM.

Nucleic Acids Res. 2009 Jan;37(Database issue):D41-8. doi: 10.1093/nar/gkn702. Epub 2008 Oct 22.

22.

Shear bond strength between feldspathic CAD/CAM ceramic and human dentine for two adhesive cements.

Graiff L, Piovan C, Vigolo P, Mason PN.

J Prosthodont. 2008 Jun;17(4):294-9. doi: 10.1111/j.1532-849X.2007.00294.x. Epub 2008 Feb 5.

PMID:
18266655

Supplemental Content

Loading ...
Support Center